Earnings Analyzer
Stock earnings page

NRX Pharmaceuticals, Inc. (NRXP)

Track the next or latest earnings date for NRX Pharmaceuticals, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.

Recent earnings news

Equities Analysts Offer Predictions for NRXP Q1 Earnings
www.marketbeat.com · April 28, 2026

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Free Report) - Research analysts at HC Wainwright issued their Q1 2027 earnings estimates for NRx Pharmaceuticals in a note issued to investors on Monday, April 27th. HC Wainwright analyst P. Trucchio expects that the company will post earnings per share of $

NRx Pharmaceuticals Q1 Earnings Call Highlights
finance.yahoo.com · May 18, 2026

NRx Pharmaceuticals (NASDAQ:NRXP) said it advanced several regulatory, manufacturing and clinical initiatives during the first quarter of 2026, including progress toward potential approval of its preservative-free ketamine product, KETAFREE, and preparations for an NDA filing for NRX-100. Founder,

NRXP: NRX Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas
stocktwits.com · 3 weeks ago

Get real-time NRX Pharmaceuticals Inc (NRXP) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

NRx Pharmaceuticals, Inc. (NRXP) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com · May 15, 2026

NRx Pharmaceuticals (NRXP) delivered earnings and revenue surprises of +20.00% and -91.28%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

NRX Pharmaceuticals Inc (NRXP) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...
finance.yahoo.com · 3 weeks ago

Additional Funding: $7 million raised post-quarter through sale of common stock. Warning! GuruFocus has detected 3 Warning Signs with NRXP. Is NRXP fairly valued? Test your thesis with our free DCF calculator. ... For the complete transcript of the earnings call, please refer to the full earnings ..…

Latest earnings date

Mar 20, 2026

Time not specified

Fiscal quarter: 2025-12-31

EPS estimate: -$0.09

Revenue estimate: N/A

Market cap: $62.15M

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week
Date Quarter Report window EPS est. Revenue est.
Mar 20, 2026 2025-12-31 Time not specified -$0.09 N/A